Synapse - Larry Norton

Search Within

Larry Norton

Results (200)

A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard peri-operative care in women with residual triple negative early stage/resectable breast cancer after standard-of-care neoadjuvant chemotherapy

Meeting Abstract

McArthur, H. L.; Comen, E. A.; Solomon, S.; Rodine, M.; DiLauro Abaya, C.; Leal, J. H. S.; Patil, S.; Norton, L.
Cancer Research (2019)

Fulltext@MSK | Save

Tumor epichaperome expression using (124)I PU-H71 PET (PU-PET) as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2 negative (HER2-) metastatic breast cancer (MBC)

Meeting Abstract

Jhaveri, K.; Dunphy, M.; Wang, R.; Comen, E.; Fornier, M.; Moynahan, M. E.; Bromberg, J.; Ma, W.; Patil, S.; Taldone, T.; more...
Cancer Research (2019)

Fulltext@MSK | Save

Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with human epidermal growth receptor 2 overexpressing metastatic breast cancer: 5-year follow-up

Journal Article

Wang, R.; Smyth, L. M.; Iyengar, N.; Chandarlapaty, S.; Modi, S.; Jochelson, M.; Patil, S.; Norton, L.; Hudis, C. A.; Dang, C. T.
The Oncologist (2019)

Fulltext@MSK | Save

Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy

Journal Article

Krystel-Whittemore, M.; Xu, J.; Brogi, E.; Ventura, K.; Patil, S.; Ross, D. S.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; more...
Breast Cancer Research and Treatment (2019)

Fulltext@MSK | Save

Phase I study of intermittent high-dose lapatinib alternating with capecitabine for HER2-positive breast cancer patients with central nervous system metastases

Journal Article

Morikawa, A.; de Stanchina, E.; Pentsova, E.; Kemeny, M. M.; Li, B. T.; Tang, K.; Patil, S.; Fleisher, M.; Van Poznak, C.; Norton, L.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

Assessment of quality of life and treatment outcomes of patients with persistent postchemotherapy alopecia

Journal Article

Freites-Martinez, A.; Chan, D.; Sibaud, V.; Shapiro, J.; Fabbrocini, G.; Tosti, A.; Cho, J.; Goldfarb, S.; Modi, S.; Gajria, D.; more...
JAMA Dermatology (2019)

Fulltext@MSK | Save

Longer follow-up on clinical outcomes of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2 overexpressing metastatic breast cancer

Meeting Abstract

Wang, R.; Smyth, L. M.; Iyengar, N. M.; Modi, S.; Chandarlapaty, S.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C. A.; Dang, C. T.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Phase I study of intermittent high-dose lapatinib alternating with capecitabine for HER2-positive breast cancer with central nervous system metastases

Meeting Abstract

Morikawa, A.; Pentsova, E.; Kemeny, M.; Patil, S.; Li, B. T.; Tang, K.; Fleisher, M.; Van Poznak, C. H.; Norton, L.; Seidman, A. D.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Phase II study of paclitaxel and dasatinib in metastatic breast cancer

Journal Article

Morris, P. G.; Rota, S.; Cadoo, K.; Zamora, S.; Patil, S.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C.; Dickler, M.; more...
Clinical Breast Cancer (2018)

Fulltext@MSK | Save

Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer

Journal Article

Chen, F.; Ma, K.; Madajewski, B.; Zhuang, L.; Zhang, L.; Rickert, K.; Marelli, M.; Yoo, B.; Turker, M. Z.; Overholtzer, M.; more...
Nature Communications (2018)

Fulltext@MSK | Save